Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T69847 |
O-1057 free base
|
||
O-1057 free base is a water-soluble cannabinoid receptor agonist with antinociceptive properties. RESEARCH USE ONLY. | |||
T69848 |
O-1057 hydrochloride
|
||
O-1057 hydrochloride is a water-soluble cannabinoid receptor agonist with antinociceptive properties. RESEARCH USE ONLY. | |||
T69846 |
VTP50469 mesylate
|
||
VTP-50469 is a novel, potent, selective, orally-available MeninMLL1 inhibitor, being effectively against MLL-rearranged and NPM1c+ leukemia, selectively killing cell lines with MLLrearrangements and NPM1c+ mutations. | |||
T36577 |
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt)
K-Biotin-W-Histone H2B (108-125) (trifluoroacetate salt) |
||
Histone H2B (108-125) is a peptide fragment of histone H2B that corresponds to amino acid residues 109-126 of the human histone H2B sequence. It contains an N-terminal biotinylated lysine followed by a tryptophan linker. Histone H2B can be modified by addition of an O-linked N-acetylglucosamine (GlcNAc) moiety to the serine residue at position 112, which promotes monoubiquitination of the lysine at position 120.1 Both of these modifications are associated with active transcription. Histone H2B a... |